Fig. 4
From: IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients
The comparison of anti-SARS-CoV-2 IgG APR and Ab levels in BCL (A and B) and DLBCL (C and D) patients treated with and without BTKi
Fig. 4 | BMC Immunology